共 142 条
[1]
De Groen PC(1999)Biliary tract cancers N Engl J Med 341 1368-78
[2]
Gores GJ(2003)Cholangiocarcinoma: current concepts and insights Hepatology 5 961-9
[3]
LaRusso NF(2004)Gallbladder and biliary tract carcinoma: A comprehensive update, Part 1 Oncology (Huntingt) 18 889-96
[4]
Gunderson LL(1990)Pharmacollogically directed design of the dose rate and schedule of 2, 2-dideoxy-fluorocytidine (Gemcitabine) administration in leukemia Cancer Res 50 6823-6
[5]
Nagorney DM(1996)Gemcitabine: Preclinical pharmacology and mechanisms of action Semin Oncol 23 3-15
[6]
Gores GJ(1995)Schedule-dependent antitumor effect of gemcitabine in in vivo model systems Semin Oncol 22 42-6
[7]
Rajagopalan V(1996)Antitumor activity of prolonged as compared with bolus administration of 2, 2-difluorodeoxycytidine in vivo against murine colon tumors Cancer Chemother Pharmacol 38 335-42
[8]
Daines WP(2002)Toxicity of a 24-hour infusion of gemcitabine in biliary tract and pancreatic cancer: A pilot study Cancer Invest 20 180-5
[9]
Grossbard ML(2003)Phase II trial of a 24-hour infusion of gemcitabine in previously untreated patients with advanced pancreatic adenocarcinoma Cancer Invest 21 690-4
[10]
Kozuch P(2000)New guidelines to evaluate the response to treatment in solid tumors J Natl Cancer Inst 92 205-16